基于血糖控制持久性的年轻成人2型糖尿病长期结局:TODAY队列研究结果
TODAY队列研究纳入457例平均年龄14岁、平均糖尿病病程<2年的2型糖尿病青少年,随访至少10年,评估不同持久血糖控制模式对合并症的影响及空腹血糖变异性的作用。结果显示基线HbA1c较高、β细胞功能较低及母亲糖尿病史与血糖控制丧失强相关;4年累积HbA1c较高和诊断后3年内1年空腹血糖变异性较大与后续10年血脂异常、肾病和视网膜病变进展患病率较高相关;空腹血糖变异系数≥8.3%可预测未来血糖控制丧失和合并症发生。
要点
- 基线HbA1c较高、β细胞功能较低和母亲糖尿病史与青少年2型糖尿病血糖控制丧失强相关。
- 4年累积HbA1c较高和诊断后3年内1年空腹血糖变异性较大与后续10年血脂异常、肾病和视网膜病变进展患病率较高相关。
- 空腹血糖变异系数≥8.3%可预测未来血糖控制丧失和合并症发生。
核心结论
- 基线HbA1c较高和诊断后第1年空腹血糖变异性可准确预测将发生代谢失代偿和合并症的青少年2型糖尿病患者。
- 这些数值可能成为临床医生考虑早期强化治疗时有用的工具。
研究设计与样本
- 来自TODAY研究(Treatment Options for Type 2 Diabetes in Adolescents and Youth)的分析,纳入457例参与者,平均年龄14岁,入组时平均糖尿病病程<2年,最低研究随访10年。
- 纵向测量HbA1c、空腹血糖浓度和口服葡萄糖耐量试验的β细胞功能估计值,评估TODAY研究10年后按血糖控制状态的合并症患病率。
主要发现
- 较高的基线HbA1c浓度、较低的β细胞功能和母亲糖尿病史与青少年2型糖尿病血糖控制丧失强相关。
- 4年累积HbA1c浓度较高和诊断后3年内1年空腹血糖变异性较大与后续10年血脂异常、肾病和视网膜病变进展患病率较高相关。
- 空腹血糖变异系数≥8.3%可预测未来血糖控制丧失和合并症发生。
关键数值与推荐
- 空腹血糖变异系数≥8.3%可预测未来血糖控制丧失和合并症发生。
临床怎么用
- 作者认为基线HbA1c较高和诊断后第1年空腹血糖变异性可能成为临床医生考虑早期强化治疗时有用的工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the effect of different patterns of durable glycemic control on the development of comorbidities among youth with type 2 diabetes (T2D) and to assess the impact of fasting glucose (FG) variability on the clinical course of T2D. RESEARCH DESIGN AND METHODS: From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, 457 participants (mean age, 14 years) with mean diabetes duration <2 years at entry and a minimum study follow-up of 10 years were included in these analyses. HbA1c, FG concentrations, and β-cell function estimates from oral glucose tolerance tests were measured longitudinally. Prevalence of comorbidities by glycemic control status after 10 years in the TODAY study was assessed. RESULTS: Higher baseline HbA1c concentration, lower β-cell function, and maternal history of diabetes were strongly associated with loss of glycemic control in youth with T2D. Higher cumulative HbA1c concentration over 4 years and greater FG variability over a year within 3 years of diagnosis were related to higher prevalence of dyslipidemia, nephropathy, and retinopathy progression over the subsequent 10 years. A coefficient of variability in FG ≥8.3% predicted future loss of glycemic control and development of comorbidities. CONCLUSIONS: Higher baseline HbA1c concentration and FG variability during year 1 accurately predicted youth with T2D who will experience metabolic decompensation and comorbidities. These values may be useful tools for clinicians when considering early intensification of therapy.
引用
- Long-term Outcomes Among Young Adults With Type 2 Diabetes Based on Durability of Glycemic Control: Results From the TODAY Cohort Study. Diabetes Care. 2022. PMID: 36190810. doi:10.2337/dc22-0784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。